XML 69 R57.htm IDEA: XBRL DOCUMENT v3.23.3
COMMITMENTS AND CONTINGENCIES - Employment Agreement (Details) - Employment Agreement - CEO - USD ($)
12 Months Ended
Oct. 29, 2021
Jun. 30, 2021
Jul. 28, 2017
Sep. 30, 2023
Jun. 30, 2017
COMMITMENTS AND CONTINGENCIES          
Agreement renewal period   1 year 1 year   1 year
Special cash incentive bonus     $ 800,000    
Special cash incentive bonus payable on completing threshold annual revenue     300,000    
Threshold annual revenue     8,000,000    
Special cash incentive bonus payable on completing threshold annual revenue in excess of first threshold     100,000    
Threshold annual revenue in excess of first threshold     2,000,000    
Annual salary $ 450,000   $ 400,000    
Compensation description     The agreement with Dr. Hayward also provides that if he is terminated before the end of the initial or a renewal term by the Company without cause or if Dr. Hayward terminates his employment for good reason, then, in addition to previously earned and unpaid salary, bonus and benefits, and subject to the delivery of a general release and continuing compliance with restrictive covenants, Dr. Hayward will be entitled to receive a pro rata portion of the greater of either (X) the annual bonus he would have received if employment had continued through the end of the year of termination or (Y) the prior year's bonus; salary continuation payments for two years following termination equal to the greater of (i) three times base salary or (ii) two times base salary plus bonus; company-paid COBRA continuation coverage for 18 months post-termination; continuing life insurance benefits (if any) for two years; and extended exercisability of outstanding vested options (for three years from termination date or, if earlier, the expiration of the fixed option term). If termination of employment as described above occurs within six months before or two years after a change in control of the Company, then, in addition to the above payments and benefits, all of Dr. Hayward's outstanding options and other equity incentive awards will become fully vested and Dr. Hayward will receive a lump sum payment of the amounts that would otherwise be paid as salary continuation. In general, a change in control will include a 30% or more change in ownership of the Company.    
Approved bonus       $ 500,000  
Revenue bonus recorded to long term accrued liabilities       $ 12,000,000